Vaccine-Based Prevention of Meningococcal B Disease: Tools for Interpreting and Implementing Recommendations

Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country. The disease can develop from initial symptoms to death within 24 hours. Given how disabling this disease can be it is essential health care workers, who deliver vaccinations, enhance their standards of care in practice in order to deliver the highest rates of preventative care in this area. The goal of the activity is to improve comprehension and initiate practice changes so as to improve immunization rates for all patients who are currently scheduled for the MenB vaccination.

Target Audience

Primary care clinicians, pediatricians, nurses, pharmacists, physician assistants, and all clinicians who treat children/adolescents who are scheduled to receive the MenB vaccine.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Differentiate between types of meningococcal vaccinations with respect to serotypes covered, administration schedule, impact on herd protection and tolerability.
  2. Interpret Category A and B recommendations in order to better discuss meningococcal B vaccination for patients.
  3. Utilizing case-based video vignettes, implement strategies to improve uptake of meningococcal B vaccine in clinical practice.

Additional Information

Partner: 
myCME
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
03/09/2021
Course expires: 
03/09/2022
Rating: 
0

Stephen I. Pelton, MD
Course Director
Professor of Pediatrics
Boston University School of Medicine
Professor of Epidemiology
Boston University School of Public Health
Director, Section of Pediatric Infectious Diseases
Boston Medical Center

Dr. Pelton receives Grant/Research/Clinical Trial Support from Pfizer, Merck and Cempra. He is a consultant for Pfizer, GlaxoSmithKline, Sanofi Pasteur and Seqirus.

Gary Marshall, MD
Professor of Pediatrics,
Chief, Division of Pediatric Infectious Diseases
University of Louisville School of Medicine
Louisville, KY

Dr. Marshall receives grant and research support from GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur and Seqirus. He is a speaker for Sanofi Pasteur.

Carole Moloney, RN, MSN, CPNP
Clinical Instructor of Pediatrics
Boston University School of Medicine
Boston, Massachusetts

Dr. Moloney is on the speaker’s bureau for Sanofi Pasteur.

Accredited Provider

Provided by Boston University School of Medicine

AMA PRA Category 1 Credit TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Contact Hour(s)

Accreditation Statement

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

Contact Hours: 1.00. Pharmacotherapy Hours: 1.00.

CE for Pharmacists

Accreditation Statement

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

This is a knowledge-based educational activity. Pharmacists will receive 1.00 contact hour (0.1 ceus) for the enduring educational activity. No partial credit is available. UAN: 0060-9999-21-012-H06-P

AAFP Credits

Accreditation Statement

The AAFP has reviewed "Vaccine-Based Prevention of Meningococcal B Disease: Tools for Interpreting and Implementing Recommendations" and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Elective credit. Approval is from 02/26/2021 to 02/26/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Designation Statement

Approved for 1.00 AAFP Prescribed credits

AAP Credits

Accreditation Statement

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Designation Statement

1.00 AAP credits

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through myCME. 

To take this course you will be redirected to myCME's website. You must login or create an account with myCME in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!